IFNG and Parkinson disease: Past studies reported that IFN-γ deficiency attenuated dopaminergic lesions in PD models by inhibiting microgliosis and inducible NO synthase (iNOS) expression, indicating that IFN-γ may contribute to dopaminergic loss by acting through microglial activation34,35.